Delivery Order SPE2DB22D3004-SPE2DB25FSH89
- Not listed
- The Defense Logistics Agency awarded a $1,360.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injectors with a completion date of June 2, 2025. This non-set-aside competitive award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $5,758.57 firm fixed-price delivery order on August 14, 2025, for Mounjaro 2.5 mg/0.5 mL pen injections, with an ultimate completion date of August 15, 2025. The contract, issued without set-aside designation, represents a competitively awarded procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $11,461.68 delivery order to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 mL pen injectors on July 14, 2025, with completion targeted for July 15, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a GLP-1 receptor agonist used in diabetes management, consistent with...
- The Defense Logistics Agency awarded a $1,632.54 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injectors on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed price contract represents a competitively awarded, non-set-aside procurement and is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,825.26 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors on August 13, 2025, with completion scheduled for August 14, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a $19,091.85 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $11,766.11 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors on September 11, 2025, with completion scheduled for September 12, 2025. This is a firm fixed-price, non-set-aside contract with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor on a larger Indefinite Delivery Contract, for the supply of Mounjaro 5 mg/0.5 ml pen injectors valued at $3,482.67. This delivery order, issued on September 15, 2025, represents a firm fixed-price procurement with an ultimate completion date of September 16, 2025. The contract was competitively awarded without set-aside designation and will be performed at the vendor's corporate office...
- The Defense Logistics Agency awarded a $1,632.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 5, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors (0.5 mL units). The contract was competitively awarded with no set-aside designation and maintains an ultimate completion date of May 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pen injectors with a firm fixed price ceiling value of $6,333.60. The contract was competitively awarded without a set-aside designation and carries an ultimate completion date of September 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSH89Delivery Order
The Defense Logistics Agency awarded a $11,848.28 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors (0.5 ml). The contract was competitively awarded without set-aside designation and is scheduled for completion by September 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. Mounjaro is a GLP-1 receptor agonist medication used for diabetes management, reflecting the Defense Logistics Agency's broader pharmaceutical supply mission supporting military healthcare systems and federal medical procurement needs. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal medical supply contracts with the DLA and serves critical healthcare requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The firm fixed pricing structure and competitively awarded status demonstrate the contractor's capability to meet federal procurement standards for pharmaceutical distribution within the established IDC framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 9/5/25 |